Biogen (BIIB) Exchange Rate Effect (2009 - 2026)
Biogen (BIIB) recorded quarterly Exchange Rate Effect of -$18.0 million in Q1 2026, down 820.0% quarter-over-quarter from $2.5 million in Q4 2025, and down 152.48% on a YoY basis from $34.3 million in Q1 2025.
Biogen (BIIB) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Biogen's Exchange Rate Effect history runs 18 years deep, the most recent figure standing at -$18.0 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 152.48% year-over-year to -$18.0 million; the TTM figure through Mar 2026 stood at $49.6 million (up 581.55% YoY), while the FY2025 annual figure was $101.9 million, up 250.52% from the prior year.
- Exchange Rate Effect was -$18.0 million for Q1 2026 at Biogen, down from $2.5 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $68.3 million in Q2 2025 to a low of -$74.4 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$258823.5 across 5 years, with a median of -$4.1 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect slumped 525.0% in 2022, then soared 642.06% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $67.2 million in 2022, then dropped by 28.72% to $47.9 million in 2023, then slumped by 255.32% to -$74.4 million in 2024, then surged by 103.36% to $2.5 million in 2025, then slumped by 820.0% to -$18.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$18.0 million (Q1 2026), $2.5 million (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 2.70 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 67.00 Mn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | -25.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | -12.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | -48.00 Mn |
| 10 | Biogen | 28.75 Bn | 24.47 Bn | 1.82 Bn | -18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.00 Mn |
| Mar 31, 2026 | -18.00 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | -3.20 Mn |
| Sep 30, 2025 | -3.20 Mn |
| Jun 30, 2025 | 68.30 Mn |
| Jun 30, 2025 | 68.30 Mn |
| Mar 31, 2025 | 34.30 Mn |
| Mar 31, 2025 | 34.30 Mn |
| Dec 31, 2024 | -74.40 Mn |
| Dec 31, 2024 | -74.40 Mn |
| Sep 30, 2024 | 42.40 Mn |
| Sep 30, 2024 | 42.40 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -23.10 Mn |
| Mar 31, 2024 | -23.10 Mn |
| Dec 31, 2023 | 47.90 Mn |
| Dec 31, 2023 | 47.90 Mn |